What You Should Know:
– Cardinal Health (NYSE: CAH) has announced a definitive agreement to acquire Integrated Oncology Network (ION), a physician-led independent community oncology network, for $1.115 billion in cash.
– The acquisition will integrate…
Continue Reading
Funding will Support Expanded Commercialization Efforts for PreciseBreast Risk Assessment
PreciseDx, a leading innovator in oncology diagnostics leveraging Artificial Intelligence (AI) for new, morphology-driven disease analysis, today announced that it has raised $20.7 million in…
What You Should Know:
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a partnership with the Agostino Gemelli University Polyclinic Foundation IRCCS (“Policlinico Gemelli”) to establish an in-house liquid biopsy testing…
Continue Reading
What You Should Know:
The American Cancer Society (ACS) and Yosemite, an oncology-focused venture capital firm, announced the selection of research grants through their Yosemite-ACS Award totaling more than $6 million.These inaugural grants will go to scientists from…
Continue Reading
What You Should Know:
– Panalgo, a provider of healthcare data analytics solutions, has announced a partnership with COTA, an organization focused on providing real-world data (RWD) for cancer care.
– The strategic collaboration will enable…
Continue Reading
What You Should Know:
– Paige, a provider of next-generation artificial intelligence has introduced Paige Alba, a groundbreaking clinical-grade multimodal co-pilot designed to transform personalized medicine and precision oncology.
– Leveraging the power of Paige’s Foundation…
Continue Reading
Shelli Pavone, CEO & President, Inlightened
Last month was Cancer Research Awareness Month, which is a great time to celebrate recent findings that the number of adults enrolled in oncology clinical trials has increased –…
Continue Reading
Quincy Weatherspoon, Vice President and General Manager of Flatiron Point of Care Solutions
What You Should Know:
– Flatiron Health, a pioneer in oncology technology, announced today the appointment of Quincy Weatherspoon as Vice President and…
Continue Reading
What You Should Know:
– CancerIQ, a Chicago, IL-based precision health platform focused on empowering healthcare providers to personalize cancer prevention and early detection announced it has secured a growth funding package from Decathlon Capital…
Continue Reading
What You Should Know:
– PreciseDx, a pioneering company in oncology diagnostics utilizing artificial intelligence (AI) raises $20.7M in Series B funding led by Eventide Asset Management with participation from Labcorp, Quest Diagnostics, GenHenn Capital…
Continue Reading
